- Home
- SSL vs SLNO Comparison
SSL vs SLNO Comparison
Compare SSL & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSL
- SLNO
- Stock Information
- Founded
- SSL 1950
- SLNO 1999
- Country
- SSL South Africa
- SLNO United States
- Employees
- SSL N/A
- SLNO N/A
- Industry
- SSL Oil & Gas Production
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SSL Energy
- SLNO Health Care
- Exchange
- SSL Nasdaq
- SLNO Nasdaq
- Market Cap
- SSL 4.0B
- SLNO 3.7B
- IPO Year
- SSL N/A
- SLNO 2014
- Fundamental
- Price
- SSL $6.33
- SLNO $67.16
- Analyst Decision
- SSL
- SLNO Strong Buy
- Analyst Count
- SSL 0
- SLNO 9
- Target Price
- SSL N/A
- SLNO $116.78
- AVG Volume (30 Days)
- SSL 1.2M
- SLNO 1.3M
- Earning Date
- SSL 01-01-0001
- SLNO 11-04-2025
- Dividend Yield
- SSL N/A
- SLNO N/A
- EPS Growth
- SSL N/A
- SLNO N/A
- EPS
- SSL 0.59
- SLNO N/A
- Revenue
- SSL $14,028,282,389.00
- SLNO $32,656,999.00
- Revenue This Year
- SSL N/A
- SLNO N/A
- Revenue Next Year
- SSL $5.73
- SLNO $181.30
- P/E Ratio
- SSL $10.48
- SLNO N/A
- Revenue Growth
- SSL N/A
- SLNO N/A
- 52 Week Low
- SSL $2.78
- SLNO $41.50
- 52 Week High
- SSL $7.25
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- SSL 54.97
- SLNO 52.55
- Support Level
- SSL $6.06
- SLNO $66.12
- Resistance Level
- SSL $6.65
- SLNO $72.55
- Average True Range (ATR)
- SSL 0.14
- SLNO 3.44
- MACD
- SSL 0.07
- SLNO 0.46
- Stochastic Oscillator
- SSL 77.30
- SLNO 41.99
About SSL Sasol Ltd.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: Southern Africa Energy & Chemicals business; and International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business. The company operates coal mines and its upstream interests in oil and gas, both of which are used as feedstock in the company's energy and chemicals operations. Geographically the company generates the majority of its revenue from South Africa.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.